The surging demand for novel tryptophan analogues across small-molecule, bioactive peptide, and conjugate therapeutic modalities underscores an unmet synthetic need for efficient access to (2S,3R)-β-methyltryptophans. Herein, we describe a practical and stereospecific synthesis of (2S,3R)-β-methyltryptophans that offers broad functional group compatibility and structural diversity.